Skip to content

Quantoom Biosciences

Open bankruptcy
Public limited companyfounded 2020rue de la Maitrise 11, 1400 Nivelles, BelgiumKBO/BCE: BE 0744.643.858
Summary

A bankruptcy procedure is open for Quantoom Biosciences according to publications in the Belgian Official Gazette. The 2023 annual accounts show negative equity (-€1.2m) and a net result of -€14.2m.

Quantoom BiosciencesOpen bankruptcy

Are you a creditor?

Open bankruptcy Source: Belgian Official Gazette

If this company owes you money, you are not paid automatically: you file your claim yourself, within the deadline the judgment sets.

The procedure

Court
Enterprise Court of Hainaut, Charleroi division
Declared bankrupt
20 October 2025
Supervising judge
Anne Prignon
Official Gazette
27-10-2025 (pdf) ↗search the document for 2025/143676

Deadlines

Provisional date payments stopped
20 October 2025A later judgment can change the date.art. XX.105, Code of Economic Law
Appeal or third-party opposition until
passed on 11 November 2025Fifteen days after the publication in the Official Gazette.art. XX.108, Code of Economic Law
File the claim in RegSol, the Belgian insolvency register, until
passed on 19 November 2025art. XX.104 and XX.155, Code of Economic Law
First verification report
passed on 17 December 2025Reclaim goods that are still yours, such as goods delivered under retention of title, before this day.art. XX.104 and XX.194, Code of Economic Law
Late claim until
20 October 2026A late claim shares only in what has not yet been paid out, and you bear its costs.art. XX.165, Code of Economic Law

Trustees

What to do now

  1. Stop delivering on credit unless the trustee agrees.
  2. Gather your documents: invoices, purchase orders, contract, delivery notes and reminders.
  3. File your proof of claim in RegSol (regsol.be), yourself with eID or itsme, or through your lawyer. State principal, interest and costs separately, and any preferential right you hold.
  4. Delivered under retention of title? Reclaim your goods before the first report on the verification of claims.
  5. Ask your accountant about the VAT on the unpaid invoices: in a bankruptcy it can be recovered, subject to conditions.
  6. Follow the file in RegSol: the verification report (admitted or disputed) and the trustee's reports appear there.

These deadlines come from the publication of the judgment. Check them in RegSol before you file anything; once a deadline has passed, it is too late for that step.

File a claim in RegSol ↗ Follow Follow this bankruptcy: you are alerted when it is closed or reversed.

General information, not legal advice. If in doubt, the trustee, your lawyer or your accountant can help.Creditor guide for this company

Embed in an article

Writing about this bankruptcy? Embed the Quantoom Biosciences company card in your article: name, enterprise number, its status in the KBO and the latest annual accounts, with a link to this dossier.

Preview
The preview appears here.
  • Stays current: the status follows the register, the figures are those of the latest filed accounts. No Checked score or verdict.
  • Light on your page: one small script and one data request, also answered from a cache; no cookies, no tracking.
  • Where scripts do not run (a newsletter, a feed reader) a plain link remains.

Overview

Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE 21201
3 sites
Size
€17.3moperating revenue 2023
Staff
69.1 FTE
Equity
-€1.2m
Loss
-€14.2m
Financial health
Open bankruptcy: no score
Structure
Parent
UNIVERCELLS · 100%
3 of 15 deeds read
Signalsraises riskOpen bankruptcyneutralLatest accounts filed on timeShow the evidence

Signals

Two signals.
raises riskneutral
raises risk · Open bankruptcy
Active bankruptcy procedure in the Belgian Official Gazette. Claims are handled by the appointed trustee. The KBO register also records: open bankruptcy.
Belgian Official Gazette
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2023 was due by 31-07-2024 and was filed on 04-07-2024, 27 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2024
not filed
2023
27 days early
2022
19 days early
2021
9 days early
2020
43 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 25 days before the deadline; the sector median (NACE 21) for financial year 2024 is 9 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. OpeningEnterprise Court of Hainaut, Charleroi…
  2. Capital & shares · Amendment of…Auditor report · Capital increase…
  3. RestructuringDemerger · Shareholding · Accounting…

Key points

  • Risk: Declared bankrupttrustee: Isabelle Bronkaert 20-10-2025 View
  • Controlled by UNIVERCELLS 100% View
  • EU supportawarded from 2023 to 2025 €4.2m View
  • Positive: Staff rose in 2023from 49.4 FTE to 69.1 FTE ▲ 39.9% View

By topic

Financials

Financial year
2023
Turnover
€8.3m
Loss
-€14.2m
Solvency
-2.1%
Go to Financials

Timeline

Events
10
Since
2021
  1. 04-07-2024Annual accounts filed
  2. 26-02-2024Resignations: Aziz Kabeer, Pierre Morgon and Jean…
  3. 31-12-2023Weakest financial year
Go to Timeline

Company details

Sites
3
Legal form
Public limited company
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21201
Founded
02-03-2020
Year ends
31-12
Peppol
Not found in the Peppol directory
Go to Company details

Articles of association

Provisions read
3
Purpose
“Favoriser le développement de la recherche médicale et biomédicale au sens large en vue…” (deed in French)
Go to Articles of association

Go further with this company

Investigating this company? Keep it with today's facts in a case file.